Yunzu Edward, IreneMaritim, Patricia2025-07-212025-07-212025-07-18https://doi.org/10.1371/journal. pone.0327737https://repository.must.ac.tz/handle/123456789/347This article was published bySchistosomiasis is endemic in Tanzania, with a prevalence ranging between 12.7% to 87.6%. Mass drug administration (MDA) with praziquantel is the main recommended choice of preventive treatment for the disease. Low treatment coverage rates (46.6%) in Busega District, Northwestern Tanzania which are far less than the recommended effective coverage rates of ≥ 75% could indicate low acceptability and poor uptake of MDA. This study sought to establish factors associated with acceptability of schisto somiasis mass drug administration among primary school children in Busega District.en-USArticle